Ensign Peak Advisors
MRK icon

Ensign Peak Advisors’s Merck MRK Stock Holding History

Ensign Peak Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$432M Buy
3,364,831
+751,822
+29% +$88M 0.71% 21
2026
Q1 		$314M Buy
2,613,009
+774,766
+42% +$89.4M 0.59% 27
2025
Q4 		$193M Sell
1,838,243
-933,782
-34% -$87.7M 0.34% 55
2025
Q3 		$233M Sell
2,772,025
-379,724
-12% -$31.3M 0.38% 48
2025
Q2 		$249M Buy
3,151,749
+536,384
+21% +$42.6M 0.43% 48
2025
Q1 		$235M Sell
2,615,365
-56,207
-2% -$5.25M 0.45% 46
2024
Q4 		$266M Sell
2,671,572
-1,035,243
-28% -$107M 0.47% 44
2024
Q3 		$421M Sell
3,706,815
-392,028
-10% -$46.6M 0.74% 21
2024
Q2 		$507M Sell
4,098,843
-832,195
-17% -$107M 0.93% 15
2024
Q1 		$651M Sell
4,931,038
-164,159
-3% -$20.2M 1.19% 12
2023
Q4 		$555M Sell
5,095,197
-303,289
-6% -$31.5M 1.1% 12
2023
Q3 		$556M Buy
5,398,486
+122,990
+2% +$13.3M 1.19% 13
2023
Q2 		$609M Sell
5,275,496
-119,276
-2% -$13.5M 1.23% 14
2023
Q1 		$574M Buy
5,394,772
+532,288
+11% +$57.5M 1.24% 13
2022
Q4 		$539M Buy
4,862,484
+71,207
+1% +$7.28M 1.22% 11
2022
Q3 		$413M Buy
4,791,277
+469,758
+11% +$41.9M 1.03% 14
2022
Q2 		$394M Buy
4,321,519
+2,362,744
+121% +$209M 0.94% 17
2022
Q1 		$161M Buy
1,958,775
+532,676
+37% +$42M 0.33% 69
2021
Q4 		$109M Sell
1,426,099
-1,315,527
-48% -$105M 0.21% 106
2021
Q3 		$206M Sell
2,741,626
-208,676
-7% -$15.9M 0.43% 56
2021
Q2 		$229M Sell
2,950,302
-697,244
-19% -$51.9M 0.46% 55
2021
Q1 		$268M Sell
3,647,546
-452,455
-11% -$33.4M 0.58% 34
2020
Q4 		$320M Sell
4,100,001
-237,474
-5% -$18.2M 0.73% 26
2020
Q3 		$343M Sell
4,337,475
-575,311
-12% -$45.1M 0.87% 18
2020
Q2 		$363M Sell
4,912,786
-521,551
-10% -$39.3M 0.99% 14
2020
Q1 		$399M Buy
5,434,337
+606,712
+13% +$47.7M 1.34% 10
2019
Q4 		$419M Buy
+4,827,625
New +$397M 1.11% 11

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ensign Peak Advisors's MRK Position: Q2 2026 in Review

Ensign Peak Advisors increased its Merck (MRK) stake by 29% in Q2 2026, buying an estimated $88M and bringing the position to 3,364,831 shares worth $432M. The position accounts for 0.71% of the portfolio, ranked #21.

Ensign Peak Advisors first reported a position in MRK in Q4 2019 and has held it in 27 quarters since. The position peaked at $651M in Q1 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Ensign Peak Advisors held 3,364,831 shares of Merck worth $432M as of Q2 2026.
  • Ensign Peak Advisors bought 751,822 Merck shares in Q2 2026, an estimated $88M.
  • Merck made up 0.71% of Ensign Peak Advisors's portfolio in Q2 2026, its #21 holding.
  • Ensign Peak Advisors first reported a position in Merck in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Merck position peaked at $651M in Q1 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.